November 7, 2018, MedPage Today 

Women who started taking a statin at the age of 50 or older had a significantly lower risk of developing any histologic type of ovarian cancer over the next decade than non-statin users did, according to a large, case-control study. The study by Daniel Cramer, MD, of Harvard Medical School in Boston, and colleagues also found that the effect was independent of use of any other concomitant medication. 

Read more.